Prophylaxis and therapy of ventricular fibrillation: bretylium reviewed and lidocaine refuted.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001627:Bethanidine / Q000627:therapeutic use; D001949:Bretylium Compounds / Q000627:therapeutic use*; D001950:Bretylium Tosylate / Q000627:therapeutic use*; D004562:Electrocardiography; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use*; D009200:Myocardial Contraction / Q000187:drug effects; D013268:Stimulation, Chemical; D014693:Ventricular Fibrillation / Q000517:prevention & control*
D000889:Anti-Arrhythmia Agents; D001949:Bretylium Compounds; D001950:Bretylium Tosylate; D008012:Lidocaine; D001627:Bethanidine